Does Preoperative Hemoglobin Independently Predict Short-Term Outcomes After Coronary Artery Bypass Graft Surgery? Melanie L. Bell, PhD, Gary K. Grunwald, PhD, Janet H. Baltz, MSN, Gerald O. McDonald, MD, Missy R. Bell, MBA, MSHA, Frederick L. Grover, MD, A. Laurie W. Shroyer, PhD The Annals of Thoracic Surgery Volume 86, Issue 5, Pages 1415-1423 (November 2008) DOI: 10.1016/j.athoracsur.2008.07.088 Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 (A–C) Prevalence and incidence of risk factors by hemoglobin level. Risk factors that are nearly constant (body surface area and sex) are not shown. Patients with missing hemoglobin measurements are not shown. The Annals of Thoracic Surgery 2008 86, 1415-1423DOI: (10.1016/j.athoracsur.2008.07.088) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Postoperative morbidity by hemoglobin levels. Complications that have an average incidence less than 1% (endocarditis, reoperation requiring bypass, and coma) are not shown. Patients with missing hemoglobin measurements are not shown. The Annals of Thoracic Surgery 2008 86, 1415-1423DOI: (10.1016/j.athoracsur.2008.07.088) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Survival curves for severe, moderate, and normal hemoglobin (Hgb) groups. (CABG = coronary artery bypass graft surgery.) The Annals of Thoracic Surgery 2008 86, 1415-1423DOI: (10.1016/j.athoracsur.2008.07.088) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions